European pharma under threat
Pharmaceuticals have long been the foundation of Europe’s industrial base. Now the sector must fight back against the threat of US biotech companies
This content is only available to IPE Members
Already an IPE Member? Sign in here
Unlock your IPE Membership Package
For unlimited access to IPE’s industry-leading market intelligence, comprising news, data and long-form content on European pensions and institutional investment.
What type of organisation do you work for?
- Secure online payment
- Free European delivery
- Best value for price
IPE Membership
IPE has created a suite of products and services for Europe’s institutional investment and pensions community.
Premium content
Pension fund interviews,
country analysis and data
country analysis and data
Opinion and analysis
Asset classes
and strategies in depth
and strategies in depth
IPE covers a good variety of very current and relevant topics. It is good to read the high-level, independent and objective perspectives from pension funds in other European countries; many of them are dealing with the same issues as we are, so it is interesting to learn from their experiences, especially when they are ahead of where we are on the curve.
Copyright © 1997–2024 IPE International Publishers Limited, Registered in England, Reg No. 3233596, VAT No. 685 1784 92. Registered Office: 1 Kentish Buildings, 125 Borough High Street, London SE1 1NP